Lung Cancer Treatment Using Immune System Wins F.D.A. Approval
Thursday, March 5, 2015 - 00:00
in Health & Medicine
Opdivo, from Bristol-Myers Squibb, which harnesses the body’s own immune system to attack tumors, was approved after strong results in a study.